Literature DB >> 1438068

Fetal nuchal fluid--physiological or pathological?--In pregnancies less than 17 menstrual weeks.

R D Wilson1, N Venir, D F Farquharson.   

Abstract

For pregnancies less than 17 menstrual weeks, increasing amounts of nuchal fluid increase the risks of chromosome abnormalities with localized nuchal fluid, diffuse nuchal fluid, cystic hygroma, and fetal hydrops having chromosomal risks of 12, 23, 50, and 78 per cent, respectively. The ultrasound appearance of localized or diffuse nuchal fluid is not a specific discriminator, but a fluid depth of greater than or equal to 5 mm may be an indicator of increased risk of fetal chromosomal abnormalities. If the fluid depth is less than 5 mm, there is a stronger negative predictive value and negative likelihood risk of a fetal chromosome abnormality. Gestational age did not improve the fluid depth predictive value. Differentiation of physiological from pathological requires chromosome analysis, serial ultrasound evaluation, and good clinical examination as a newborn and possibly as a young child. Long-term follow-up of those cases identified with resolving nuchal fluid abnormalities is not available and is required for a complete understanding of physiological and pathological aetiologies. Genetic counselling for fetal nuchal fluid would be recommended.

Entities:  

Mesh:

Year:  1992        PMID: 1438068     DOI: 10.1002/pd.1970120908

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Antenatal diagnosis of cystic hygroma or nuchal pad--report of 92 cases with follow up of survivors.

Authors:  P A Boyd; M Y Anthony; N Manning; C L Rodriguez; D G Wellesley; P Chamberlain
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

2.  Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation.

Authors:  A F Brady; P P Pandya; B Yuksel; A Greenough; M A Patton; K H Nicolaides
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.